Jianjun Xu
Union Hospital
Wuhan, 430022, China
Wuhan, 430022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
The Role of Lachnospiraceae in Liver Diseases: Recent Advances and Clinical Application Prospects.
Journal: International journal of molecular sciences
Published: July 15, 2026
Targeting taurine metabolism via PROTAC-mediated SLC6A6 degradation potentiates photodynamic therapy and reverses immunosuppression in cholangiocarcinoma.
Journal: Journal of nanobiotechnology
Published: March 29, 2026
Intrahepatic Splenosis Mimicking Hepatocellular Carcinoma: A Case Series of Eleven Patients.
Journal: Current medical imaging
Published: October 11, 2025
A review of the role of CSCs and CSC-EXOs in increasing drug resistance in breast cancer and future applications.
Journal: Critical reviews in oncology/hematology
Published: April 12, 2025
ZBP1-mediated apoptosis and inflammation exacerbate steatotic liver ischemia/reperfusion injury.
Journal: The Journal of clinical investigation
Published: February 20, 2024
Necroptosis-Mediated Synergistic Photodynamic and Glutamine-Metabolic Therapy Enabled by a Biomimetic Targeting Nanosystem for Cholangiocarcinoma.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 28, 2023
A NRF2 Regulated and the Immunosuppressive Microenvironment Reversed Nanoplatform for Cholangiocarcinoma Photodynamic-Gas Therapy.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 27, 2023
Dihydromyricetin ameliorates osteogenic differentiation of human aortic valve interstitial cells by targeting c-KIT/interleukin-6 signaling pathway.
Journal: Frontiers in pharmacology
Published: April 29, 2022
Chemo-photodynamic therapy with light-triggered disassembly of theranostic nanoplatform in combination with checkpoint blockade for immunotherapy of hepatocellular carcinoma.
Journal: Journal of nanobiotechnology
Published: September 12, 2021
High PPT1 expression predicts poor clinical outcome and PPT1 inhibitor DC661 enhances sorafenib sensitivity in hepatocellular carcinoma.
Journal: Cancer cell international
Published: July 28, 2021
A composite risk model predicts disease progression in early stages of COVID-19: A propensity score-matched cohort study.
Journal: Annals of clinical biochemistry
Published: April 08, 2021
Laparoscopic resection of hepatic epithelioid hemangioendothelioma: report of eleven rare cases and literature review.
Journal: World journal of surgical oncology
Published: July 10, 2020
Last Updated: 09/26/2026